Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Who Tells the Story of the Treatment of Androgenetic Alopecia?-A Bibliometric Analysis From 2003 to 2023

Sun Y., Lu M., Gao X., Liu Y., Ren J., Wang Y.

Narrative Review on Scar, Hair Loss, published in J Cosmet Dermatol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Cosmet Dermatol (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40887887
PMCID
PMC12399918
DOI
10.1111/jocd.70370
Citations
2

Abstract (original English)

Background Androgenetic alopecia (AGA) is a common form of nonscarring hair loss that affects both men and women, significantly influencing psychological well-being and quality of life. Although AGA accounts for over 90% of male hair loss, there has been limited bibliometric analysis to guide the direction of research and the development of treatments. Methods A thorough literature search was performed using the Web of Science database, resulting in the identification of 2203 articles on AGA treatment published between 2003 and 2023. The search was restricted to English-language peer-reviewed publications. Bibliometric analysis was conducted to assess research trends, publication growth, and key contributors in AGA treatment research. Results The United States and China emerged as the leading contributors, with major institutions such as the Mayo Clinic and Harvard Medical School making significant contributions. The research focus has shifted from traditional drug therapies to innovative treatments, such as platelet-rich plasma (PRP), and anti-androgen therapy. Key research areas included anti-androgen treatments, PRP, and microneedling, whereas emerging trends pointed to stem cell therapy and gene therapy as future directions. Conclusion The bibliometric analysis of AGA treatment research demonstrates an increasing interest in novel therapies and a transition towards more per

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansAlopeciaAndrogen AntagonistsStem Cell TransplantationBiomedical ResearchQuality of LifeBibliometricsFemaleMalePlatelet-Rich Plasma

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research